Nineteen analysts give Oklo Inc. an average rating of "Moderate Buy." The average 12-month price target stands at $84.30. Goldman Sachs, Citi, and UBS recently lowered their price targets and outlooks.
Insiders sold approximately $61.6 million in shares over the last three months. Oklo reported a quarterly EPS of -$0.27. This result missed the anticipated -$0.17. The miss reflects near-term cash burn and execution risks.
ARK Invest and other institutional investors show renewed interest in the firm. Potential upside depends on clearing regulatory hurdles for advanced nuclear technology.